Skip to content

13F-HR filed by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB filed this 13F-HR for the quarter ended 2016-03-31, filed 2016-04-19, with 92 holding rows worth $503,761,000.

Accession
0001415889-16-005562
Filed
2016-04-19
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2016

A holdings report, 92 entries on the cover page, a total value of $503,761,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $503,761,000 with VALUE read as thousands by filing date, 13F file number 028-15944. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALEXION PHARMACEUTICALS INC015351109COM121,000$16,846,000thousands by filing date
Gilead Sciences,Inc.375558103COM180,000$16,535,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM190,000$15,671,000thousands by filing date
Pfizer Inc.717081103COM475,000$14,079,000thousands by filing date
Eli Lilly and Company532457108COM195,000$14,042,000thousands by filing date
ALKERMES PLCG01767105SHS405,000$13,847,000thousands by filing date
INCYTE CORP COM45337C102Stock170,000$12,320,000thousands by filing date
CELGENE CORP151020104COM120,000$12,011,000thousands by filing date
ABIOMED INC003654100COM125,000$11,851,000thousands by filing date
ALLERGAN PLCG0177J108SHS42,000$11,257,000thousands by filing date
CVS Health Corporation126650100COM105,000$10,892,000thousands by filing date
Medtronic PlcG5960L103COM137,000$10,275,000thousands by filing date
ST JUDE MED INC790849103COM180,000$9,900,000thousands by filing date
BIOGEN INC COM09062X103Stock38,000$9,892,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock91,000$9,703,000thousands by filing date
CIGNA CORPORATION125509109COM69,000$9,470,000thousands by filing date
Bristol-Myers Squibb Company110122108COM142,000$9,071,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW75,000$8,785,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock141,712$8,725,000thousands by filing date
MEDIVATION INC58501N101COM187,000$8,598,000thousands by filing date
WALGREENS BOOTS ALLIANCE INC931427108COM100,000$8,424,000thousands by filing date
HCA Healthcare Inc40412C101COM104,000$8,117,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock125,000$7,846,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock61,000$7,804,000thousands by filing date
UnitedHealth Group Inc91324P102COM60,000$7,734,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM92,000$7,539,000thousands by filing date
AETNA INC NEW00817Y108COM67,000$7,527,000thousands by filing date
AbbVie,Inc.00287Y109COM130,000$7,426,000thousands by filing date
ENDO INTL PLCG30401106SHS260,000$7,319,000thousands by filing date
EXPRESS SCRIPTS HLDG CO30219G108COM106,000$7,281,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM525,000$7,219,000thousands by filing date
Amgen Inc.031162100COM45,000$6,747,000thousands by filing date
Elevance Health, Inc.036752103COM47,000$6,533,000thousands by filing date
MCKESSON CORP COM58155Q103Stock40,000$6,290,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM78,000$6,200,000thousands by filing date
THE COOPER COMPANIES216648402COM NEW40,000$6,159,000thousands by filing date
CENCORA INC COM03073E105Stock63,000$5,453,000thousands by filing date
DEXCOM INC COM252131107Stock75,000$5,093,000thousands by filing date
CEPHEID15670R107COM150,000$5,004,000thousands by filing date
HUMANA INC COM444859102Stock27,000$4,940,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock55,000$4,852,000thousands by filing date
CERNER CORP156782104COM86,000$4,555,000thousands by filing date
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK950,000$4,437,000thousands by filing date
ZELTIQ AESTHETICS INC98933Q108COM160,000$4,346,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock12,000$4,325,000thousands by filing date
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK225,000$4,165,000thousands by filing date
SUPERNUS PHARMACEUTICALS868459108COM270,000$4,118,000thousands by filing date
HALOZYME THERAPEUTICS INC COM40637H109Stock431,000$4,082,000thousands by filing date
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock30,000$3,917,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM600,000$3,834,000thousands by filing date
BECTON DICKINSON & CO075887109COM25,000$3,796,000thousands by filing date
LIVANOVA PLCG5509L101SHS70,000$3,779,000thousands by filing date
ENDOLOGIX INC29266S106COM435,000$3,637,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS200,000$3,314,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW105,000$3,301,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK115,000$3,197,000thousands by filing date
HEARTWARE INTL INC422368100COM100,000$3,142,000thousands by filing date
OMNICELL COM COM68213N109Stock110,000$3,066,000thousands by filing date
Lion Biotechnologies53619R102COM600,000$3,048,000thousands by filing date
CEMPRA INC15130J109COM171,000$2,996,000thousands by filing date
REVANCE THERAPEUTICS INC761330109COM170,000$2,968,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW150,000$2,886,000thousands by filing date
INSULET CORP COM45784P101Stock82,000$2,719,000thousands by filing date
XENCOR INC98401F105COMMON STOCK200,000$2,684,000thousands by filing date
EXELIXIS INC COM30161Q104Stock650,000$2,600,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock64,000$2,592,000thousands by filing date
CHIMERIX INC COM16934W106Stock500,000$2,555,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock150,000$2,537,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM40,000$2,532,000thousands by filing date
FIBROGEN INC31572Q808COM114,000$2,427,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM60,000$2,373,000thousands by filing date
MACROGENICS INC556099109COM120,000$2,250,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock105,000$2,142,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock40,000$2,119,000thousands by filing date
HOLOGIC INC436440101COM60,000$2,070,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM266,000$2,054,000thousands by filing date
Tandem Diabetes Care, Inc.875372104COM209,000$1,820,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK850,000$1,768,000thousands by filing date
CATABASIS PHARMACEUTICALS IN14875P107COM345,100$1,739,000thousands by filing date
ANTHERA PHARMACEUTCLS INC03674U201Common equity shares435,000$1,575,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM50,000$1,398,000thousands by filing date
TETRAPHASE PHARMACEUTICALS INC88165N105COMMON STOCK300,000$1,389,000thousands by filing date
REGULUS THERAPEUTICS INC75915K101COM200,000$1,386,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM50,000$1,315,000thousands by filing date
NEVRO CORP64157F103COM20,000$1,125,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock370,000$1,092,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM50,000$1,070,000thousands by filing date
AVALANCHE BIOT05337G107Common Stock154,006$796,000thousands by filing date
OREXIGEN THERAPEUTICS INC686164104COMMON STOCK1,200,000$675,000thousands by filing date
OCULAR THERAPEUTIX INC67576A100COM40,000$386,000thousands by filing date
BIND THERAPEUTICS INC05548N107Cmn133,535$294,000thousands by filing date
THRESHOLD PHARMACEUTICAL INC885807206COM NEW201,537$93,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001415889-16-005562this filing2016-04-19acceptance time not in the bulk data set